Small left ventricle in patients with heart failure with preserved ejection fraction is associated with higher mortality

31 August 2025 (13:15 - 14:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Yusuke Nakagawa

Kawanishi City Medical Center, Kawanishi (Japan)

5 More presentations in this session

Presentation thumbnail

Insights into pulmonary remodelling in heart failure with preserved ejection fraction through transpulmonary biomarker gradients

Doctor M. Dagan (Melbourne, AU)

Abstract Slides Video

Presentation thumbnail

Phenogrouping HFpEF trajectories identifies early and end-stage subtypes: a multicentre study using natural language processing

Doctor S. Brown (London, GB)

Abstract Slides Video

Presentation thumbnail

Gender-specific outcomes and treatment responses in elderly HFpEF patients: a comprehensive single-center retrospective study

Doctor K. Shi (Shanghai, CN)

Abstract Slides Video

Presentation thumbnail

Dapagliflozin versus empagliflozin in patients with heart failure with preserved ejection fraction

Doctor J. Kassab (Dallas, US)

Abstract Slides Video

Presentation thumbnail

Characteristics of pulmonary hypertension in adults with left ventricular diastolic dysfunction

Doctor S. Ratwatte (London, GB)

Abstract Slides Video

Access the full session

Session thumbnail

HFpEF issues

The Event

Event poster

ESC Congress 2025

31 August 2025 13:15 CET

You may be interested in

Congress Presentation

Small heart size and premature death in 366,484 individuals with normal ejection fraction

Congress Presentation

Left atrial-left ventricular indexed volume ratio: a potential predictor for adverse outcomes in patients with heart failure and preserved left ventricular ejection fraction

Congress Session

Heart failure phenotypes and outcomes

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources